Gemphire Therapeutics Shares Fall Over 50% in Heavy Trading -- Market Mover
10 Agosto 2018 - 12:33PM
Dow Jones News
Gemphire Therapeutics Inc. (GEMP) saw its shares drop by over
50% in Friday trading, after the company announced the termination
of a clinical trial of gemcabene. At 10:51 a.m. EDT, Gemphire
shares had fallen to $1.38, down 57.80%, in heavy trading. Earlier
in the week, the company announced it amended an agreement with
Pfizer, Inc. concerning gemcabene. Shares opened the trading week
at $7.55, and have been paused several times on Friday due to
trading volatility. (stephen.nakrosis@wsj.com)
(END) Dow Jones Newswires
August 10, 2018 11:18 ET (15:18 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Gemphire Therapeutics (NASDAQ:GEMP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Gemphire Therapeutics (NASDAQ:GEMP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Gemphire Therapeutics Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Gemphire Therapeutics Inc.